Showing 2 posts of 2 posts found.


MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial

February 27, 2017
Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir

MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …

Latest content